Tech Extends Sell-off, Cramer at J.P. Morgan Healthcare Conference, Zuckerberg Slams Apple 1/13/25

The podcast opens with a discussion on the ongoing sell-off in the tech sector following a particularly weak Futures report, largely attributed to a global bond syndrome causing yields to spike to 14-month highs. The hosts share insights regarding market indicators like oil prices at $78 and the dollar index at 110, framing an important week for bank earnings, cabinet nominee hearings, and CPI reports. They highlight pre-market movements, noting the struggles of companies like Moderna, which is cutting its sales forecast for 2025 due to reduced demand.

Mark Zuckerberg's recent comments on Joe Rogan's podcast became a hot topic, wherein he criticized Apple for not innovating since Steve Jobs and discussed corporate culture around masculinity. The hosts engage in a debate over Zuckerberg's remarks, viewing them as both incendiary and revealing concerning the cultural shifts within tech. Additionally, they examine the implications of new AI regulations introduced by the Biden Administration, which restrict AI Chip distributions, further exacerbating tech market fluctuations.

Jim Cramer reports live from the J.P. Morgan Healthcare Conference, discussing the acquisition of Intra-Cellular Therapies by Johnson & Johnson for $14.6 billion. This deal marks a significant shift in the biotech landscape, as J&J seeks to expand its portfolio targeting central nervous system disorders. The hosts acknowledge the challenges facing healthcare stocks amidst rising interest rates and ongoing environmental crises impacting public health.

The devastating California wildfires are discussed, particularly in light of their repercussions on both public health and the economy. Coverage of the situation includes estimates of insured losses nearing $30 billion and broader economic losses potentially reaching $150 billion. The challenges of securing adequate insurance coverage for affected homeowners are also addressed, signalling a broader issue of becoming an 'insurance desert' in California.

The podcast concludes with discussions surrounding potential M&A activity in the steel industry involving Cleveland-Cliffs and Nucor's renewed bid for U.S. Steel. The hosts provide insights on the impacts of tariffs, regulatory challenges, and how the incoming administration might influence these dynamics, hinting at significant shifts in the industry. This is tied to their continuous dialogue on market trends as they assess the overall economic landscape.